Niamh Coleman, MD PhD
@niamhjcoleman
Followers
251
Following
106
Statuses
42
Medical Oncologist 🇮🇪| Former Chief Fellow, ICT, MD Anderson Cancer Center | Passionate about translational cancer research, biomarker-driven clinical trials
Joined June 2022
RT @VivekSubbiah: AACR elections are here🎉 Delighted to support a great friend & PARP superstar & drug developer the one & only Dr. Tim Yap…
0
6
0
RT @VivekSubbiah: Dual Targeting of the mTOR Pathway May Enhance Antitumor Activity in Solid Malignancies via @oncl…
0
3
0
RT @DrJNaidoo: #ASCO24 Lung Orals🔥 Ph III BEAT-MESO trial @etop_ibcsg of bev+chemo +/- atezo in 1L MPM: - mOS 20.5 vs 18.1m (HR 0.84, p=0.…
0
25
0
RT @VivekSubbiah: Birds of the Early Phase drug development #PrecisionMedicine feather flock together @ASCO @SarahCannonDocs #ASCO24 #SCRI…
0
7
0
Great to be at #ASCO24 to present our work on rare BRAF non-V600 variants Grateful for collaboration &mentorship @VivekSubbiah 📣 BRAF fusions + non-V600 missense mutations are pan cancer targets 🎯 Most are oncogenic drivers 🎯 Urgent drug development needed @CancerInstIRE
0
9
44
RT @JiaJennyLiu: #ASCO24 Day 2 - great to see our EMITT-1 trial of novel ERAP1 inhibitor first in class poster presented at ASCO, and meet…
0
3
0
RT @VivekSubbiah: 🚨Hot off the press 👉Delighted to share before end of 2023 our investigator initiated study that was just published in @AA…
0
14
0
RT @VivekSubbiah: One of the greatest joys of mentorship is seeing your trainees soar! Meet @niamhjcoleman Rising star 🌟 & amazing oncolog…
0
4
0
@DrSanjayPopat @DavidHongMD Thank you! Love this, but I’m also jealous that I haven’t used this pun before!
0
0
4
RT @mirella_nardo: Thrilled to present this phase 1 of lefitolimod (TLR9 agonist) plus ipilimimab in refractory advanced tumors. It was saf…
0
6
0
📣📣METcount matters! Privileged to present MET-driven 🎯NCI MATCH subprotocols with genomic analysis at #ASCO2023 this year, supported by ⭐️ mentor @DavidHongMD We show that in METex14 tumors, identifying true PVs by METcount quantification is impactful @MDAndersonNews @NIH
2
11
56
RT @ShannonWestin: 🤯Exciting data for @gyncsm presented at #ASCO23 DT session by @MDAndersonNews Dr. Funda Meric-Bernstam! 🎯DESTINY Pan-C…
0
20
0
RT @VivekSubbiah: 💥🥁 Hot off the press 👉Just in time for the #ENAsymp22 @CCR_AACR @AACR 👉Examining Stripes on a Herd of Zebras🦓: Impact o…
0
10
0
RT @VivekSubbiah: 💥🚨It’s Friday & we have another #PrecisionMedicine FDA approved today 👉🏼FDA grants accelerated approval to futibatinib fo…
0
57
0
RT @MDAndersonNews: The @US_FDA has just approved the RET inhibitor selpercatinib for multiple tumor types based on the findings of the LIB…
0
30
0
RT @MDAndersonNews: At #ESMO22, our Dr. David Hong presents findings from the SURPASS trial, evaluating ADP-A2M4CD8, a next-generation T ce…
0
7
0
RT @VivekSubbiah: 🥁🚨Hot off the press in Lancet Oncology 👉So honored to share A MAJOR milestone in #PrecisionMedicine 👉Tumour-agnostic effi…
0
34
0